Dr. Claudia Ulbrich
Venture Partner at BioMedPartners
About
A serial biotech entrepreneur and senior executive with over 25 years building private and public life sciences companies. She co-founded and built Cardior Pharmaceuticals into an international Phase 2 organization acquired by Novo Nordisk for €1.025 billion in 2024, and previously founded LipoNova AG which IPO'd in 2006.
Colleagues at BioMedPartners
Aristotelis
Managing Partner at BioMedPartners
Aristotelis Nastos
Managing Partner at BioMedPartners
Claudia Ulbrich
Venture Partner at BioMedPartners
David Urech
Venture Partner at BioMedPartners
Dr. Aristotelis Nastos
Managing Partner at BioMedPartners
Dr. David Urech
Venture Partner at BioMedPartners
Dr. Marianna Feretzaki
Senior Associate at BioMedPartners
Dr. Markus Hosang
Managing Partner at BioMedPartners